How the Skin Microbiome Differs in Atopic Dogs: Research Insights

By Emiel Maddens · Reviewed in consultation with licensed veterinary professionals · Updated August 2026 · 9 min read

What Is the Skin Microbiome in Dogs?

The canine skin microbiome is the entire community of bacteria, fungi, viruses, and mites that live on and within the skin surface and hair follicles of a healthy dog. It is a normal, permanent feature of skin, not a sign of contamination or disease.

Before culture-independent sequencing, veterinary dermatology understood canine skin flora only through what would grow on an agar plate, which captured a tiny fraction of what is actually present. Next-generation sequencing of the 16S ribosomal RNA gene changed that picture completely. Studies using this method have shown that healthy canine skin supports a far richer community than culture ever suggested, with Proteobacteria, Firmicutes, Actinobacteria, and Bacteroidetes as the dominant phyla across most body sites.

Critically, the community is not uniform. Haired skin, mucocutaneous junctions such as the lip margin and nostril, and the ear canal each carry distinct microbial signatures. Moist and interdigital sites tend to support different populations than dry, exposed regions such as the dorsal back. This site specificity matters clinically, because the areas where atopic dogs develop lesions, namely the paws, axillae, groin, and periocular skin, are precisely the sites where microbial communities are most sensitive to changes in moisture and barrier integrity.

The working model in current veterinary dermatology is that a diverse commensal community is protective. Resident organisms occupy binding sites, consume available nutrients, produce antimicrobial peptides and bacteriocins, and help calibrate cutaneous immune signaling. When that community narrows, the protective effect narrows with it.

How Does the Microbiome of an Atopic Dog Differ From a Healthy Dog?

Atopic dogs carry a measurably less diverse skin microbiome than healthy dogs, and the imbalance intensifies during active disease. This finding has been reproduced across multiple independent sequencing studies and is now one of the more consistent observations in canine dermatology research.

Rodrigues Hoffmann and colleagues, publishing in PLoS ONE in 2014, compared allergic and healthy dogs across multiple skin sites and found that allergic dogs showed reduced microbial richness and evenness, with the reduction most pronounced at lesional sites. Bradley and colleagues, working with atopic dogs followed longitudinally through flares and treatment, reported the same directional change and added an important detail: diversity fell during the flare and partially recovered once the flare was controlled. The microbiome shift travels with the disease state rather than existing as a fixed trait of the individual dog.

The organism that expands into the vacated space is usually Staphylococcus pseudintermedius, the same coagulase-positive staphylococcus that causes most canine pyoderma. On healthy skin it is a minor resident. On lesional atopic skin during a flare it can become the single most abundant taxon recovered, in some reported cases making up more than half of all bacterial sequences at that site. Malassezia pachydermatis, the commensal yeast, follows a similar pattern in a subset of dogs, particularly in moist folds and interdigital spaces.

It is worth stating plainly what the research does not establish. These are association studies. They demonstrate that dysbiosis and atopic dermatitis occur together and change together, but they do not prove that the microbial shift causes the disease. The prevailing interpretation is bidirectional: a compromised barrier permits overgrowth, and overgrowth further inflames and degrades the barrier.

What Causes Microbial Imbalance in Atopic Skin?

Four mechanisms are repeatedly implicated, and in most atopic dogs they operate simultaneously rather than in isolation.

Barrier dysfunction. Atopic dogs show abnormalities in stratum corneum lipid organization, particularly in ceramide content and lamellar body structure. Transepidermal water loss is elevated in atopic skin compared with healthy controls, which raises local surface humidity. Both Staphylococcus and Malassezia proliferate more readily in a moist microenvironment.

Altered antimicrobial peptide activity. Healthy canine keratinocytes produce beta-defensins and cathelicidin, which selectively suppress pathogenic overgrowth while tolerating commensals. In atopic skin, the expression and function of these peptides is dysregulated, weakening one of the barrier's built in population controls.

Enhanced adherence. Staphylococcus pseudintermedius binds more readily to corneocytes harvested from atopic dogs than to those from healthy dogs. The receptive surface itself is different, which helps explain why atopic dogs develop recurrent pyoderma at the same sites over and over.

Self-trauma. Scratching, licking, and chewing physically strip the stratum corneum, seed bacteria deeper into follicles, and introduce oral flora onto skin. This is the most modifiable of the four mechanisms, and it is the reason itch control occupies such a central place in flare management.

Antimicrobial therapy is a fifth factor worth flagging. Systemic antibiotics resolve infection but also reduce commensal diversity, and recovery can take weeks. That trade off is covered in more depth in How Antibiotics Disrupt Your Dog's Skin Microbiome.

How Do Researchers Measure the Skin Microbiome?

Understanding what the studies actually measured makes their conclusions easier to interpret, and it explains why culture results from your own veterinarian will not look like published sequencing data.

What Does This Mean for Treating Atopic Dogs?

The microbiome research supports a shift in emphasis from eradication toward restoration and stabilization. Sterilizing the skin is neither achievable nor desirable, because the commensal community is part of the defense.

Three practical implications follow. First, topical therapy is preferable to systemic antibiotics where the infection is superficial and localized, because topical antimicrobials act at the site and spare the gut and distant skin sites. Second, barrier support matters as much as antimicrobial activity, since a competent barrier is what keeps the community stable between flares. Third, itch control is microbiome protection, because self-trauma is a direct mechanical driver of dysbiosis.

That third point is where antipruritic topicals earn their place. Itchy Skin Relief Spray contains pramoxine HCl 1%, a topical anesthetic that blocks sodium channel conduction in cutaneous sensory nerve endings, interrupting the itch signal before it reaches the spinal cord. Unlike a corticosteroid it does not suppress local immune function, and unlike an antimicrobial it does not act on the microbial population directly. Its contribution is upstream: by reducing the urge to scratch, it reduces the mechanical stripping of stratum corneum that opens the door to overgrowth in the first place. The colloidal oatmeal component contributes avenanthramides and beta-glucans that support the surface film. It is an FDA-registered OTC veterinary drug listed on DailyMed, not a cosmetic.

Where cytology confirms bacterial or yeast overgrowth, a chlorhexidine or ketoconazole based product is the appropriate antimicrobial layer, and it should be selected on the basis of what cytology actually shows rather than on appearance alone. If you are not sure which pattern you are looking at, the Dog Skin Condition Checker is a reasonable starting point, and Dog Skin Allergies covers the broader diagnostic pathway. For background on the two organisms that dominate this literature, see Staphylococcus pseudintermedius and Malassezia on Healthy Dog Skin.

Can the Skin Microbiome Be Restored?

Partially, and the evidence for this is more encouraging than for most chronic disease processes. The longitudinal flare studies show that microbial diversity rebounds after successful flare control, which means the dysbiotic state is not a permanent rewriting of the community.

What appears to help, based on current evidence:

Consistent flare control. Shorter and less severe flares mean less time spent in the low diversity state and less cumulative barrier damage.

Topical over systemic where clinically appropriate. This is a decision for your veterinarian, but the principle is to use the narrowest effective intervention.

Barrier directed care. Emollients, ceramide containing topicals, and dietary essential fatty acids all target the lipid matrix that governs water loss and surface humidity. Dog Skin Barrier Function covers this in detail.

Environmental stability. Bathing frequency, drying protocol, bedding hygiene, and humidity all shape the surface environment the community lives in.

Topical probiotics and bacteriotherapy are an active research area rather than an established treatment. Early work transplanting protective commensal strains onto atopic skin is promising in principle, but no product currently has the veterinary evidence base to be recommended as standard care. Topical Probiotic Therapy for Dog Skin reviews where that field currently stands.

The realistic goal for an atopic dog is not a healthy dog's microbiome. It is a stable one, held together by consistent barrier care and prompt flare management, with fewer and shorter excursions into the dysbiotic state.

Frequently Asked Questions

Do atopic dogs have less bacteria on their skin?

Not less bacteria, less variety. Atopic dogs typically carry a similar or higher total bacterial load, but far fewer distinct types. Diversity drops while a single organism, usually Staphylococcus pseudintermedius, expands to occupy the space the commensals vacated.

Can I test my dog's skin microbiome?

Not in a way that changes treatment. 16S rRNA sequencing is a research method with no validated clinical reference ranges in dogs. Your veterinarian will instead use cytology, which identifies cocci, rods, and yeast within minutes, and culture with susceptibility testing when antibiotic selection is in question.

Does bathing damage my dog's skin microbiome?

Appropriately spaced medicated bathing does not cause lasting harm and is a mainstay of managing infection in atopic dogs. Diversity dips immediately after a medicated bath and recovers within days. The larger risk is under-treating an active infection, which sustains dysbiosis for weeks.

Will probiotics fix my dog's skin microbiome?

Oral probiotics have shown modest benefit for canine atopic dermatitis severity scores in some trials, but the effect is inconsistent and appears to work through immune modulation rather than by changing skin flora. Topical bacteriotherapy is still experimental in veterinary medicine.

How long does it take for the skin microbiome to recover after antibiotics?

Published work suggests partial recovery over several weeks, with the community moving back toward its pre-treatment composition once the antibiotic course ends and the underlying inflammation is controlled. Recovery is slower when the atopic disease itself remains active.

Is atopic dermatitis caused by the microbiome?

Current evidence does not support a simple causal claim. Atopic dermatitis is a genetically influenced, immune mediated disease with a barrier defect. Dysbiosis appears to be both a consequence of that defect and a factor that worsens it, forming a self-reinforcing loop rather than an origin.

Sources

1. Rodrigues Hoffmann A, Patterson AP, Diesel A, et al. The skin microbiome in healthy and allergic dogs. PLoS ONE. 2014;9(1):e83197.
2. Bradley CW, Morris DO, Rankin SC, et al. Longitudinal evaluation of the skin microbiome and association with microenvironment and treatment in canine atopic dermatitis. Journal of Investigative Dermatology. 2016;136(6):1182-1190.
3. Older CE, Diesel A, Patterson AP, et al. The feline skin microbiota: the bacteria inhabiting the skin of healthy and allergic cats. PLoS ONE. 2017;12(6):e0178555.
4. Santoro D, Marsella R, Pucheu-Haston CM, et al. Review: pathogenesis of canine atopic dermatitis, skin barrier and host-microorganism interaction. Veterinary Dermatology. 2015;26(2):84-e25.
5. Olivry T, DeBoer DJ, Favrot C, et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals. BMC Veterinary Research. 2015;11:210.
6. Simou C, Thoday KL, Forsythe PJ, Hill PB. Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs. Veterinary Dermatology. 2005;16(6):385-391.

Related Reading

• How Antibiotics Disrupt Your Dog's Skin Microbiome and Recovery Tips
• Staphylococcus pseudintermedius: The Bacteria That Lives on Every Dog's Skin
• Dog Skin Barrier Function: Why It Matters for Allergies and Infections
• Canine Atopic Dermatitis: Complete Guide to Environmental Allergies

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Veterinary review: All Vetified content is developed in consultation with licensed veterinary professionals and references peer-reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.